Jump to main content
博士論文

A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer

Icons representing 博士論文
The cover of this title could differ from library to library. Link to Help Page

A phase II study of gemcitabine plus nab-paclitaxel as first-line therapy for locally advanced pancreatic cancer

Persistent ID (NDL)
info:ndljp/pid/12694221
Material type
博士論文
Author
深堀, 理
Publisher
-
Publication date
2021-10-01
Material Format
Digital
Capacity, size, etc.
-
Name of awarding university/degree
久留米大学,博士(医学)
View All

Notes on use at the National Diet Library

本資料は、掲載誌(URI)等のリンク先にある学位授与機関のWebサイトやCiNii DissertationsLeave the NDL website. から、本文を自由に閲覧できる場合があります。

Notes on use

Note (General):

2021年度Medicine 100(20):e26052, 2021PubMed番号 : 34011119

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Digital

Material Type
博士論文
Author/Editor
深堀, 理
Author Heading
Publication Date
2021-10-01
Publication Date (W3CDTF)
2021-10-01
Alternative Title
局所進行膵癌に対する一次治療 ゲムシタビン・ナブパクリタキセル併用療法の第Ⅱ相試験
Degree grantor/type
久留米大学
Date Granted
2021-10-01
Date Granted (W3CDTF)
2021-10-01